Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac tromethamine multimodal analgesia after total hip arthroplasty
ChiCTR2000033412Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketorolac in postoperative pain (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: VAS score during first hip flexion about 12 hours after surgery. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000033412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033412.